Skip to main content
. 2019 Aug 7;11(8):1127. doi: 10.3390/cancers11081127

Table 4.

Mean expression of mRNA expression of HLA Class I antigens and infiltrating immune cells in relation to Q209L or Q209P mutation on either GNAQ or GNA11. p-values were calculated using the Wilcoxon-Rank sum test. STD = standard deviation.

mRNA
Probe
Illumina D3
Q209L
n = 15
Mean ± STD
D3
Q209P
n = 6
Mean ± STD
M3
Q209L
n = 27
Mean ± STD
M3
Q209P
n = 11
Mean ± STD
M3 Q209L versus M3 Q209P
p-Value
D3 Q209L versus D3 Q209P
p-Value
All M3 versus All D3
p-Value
HLA_A ILMN
1671054
10.88
±0.73
10.63
±0.72
11.85
±0.79
11.60
±0.74
0.30 0.79 <0.001
HLA_A ILMN
2203950
13.35
±0.80
13.12
±0.75
14.23
±0.51
14.16
±0.55
0.87 0.91 <0.001
HLA_A ILMN
2186806
10.08
±1.63
9.39
±0.93
11.20
±1.10
11.33
±1.22
0.70 0.37 <0.001
HLA_B ILMN
1778401
10.34
±1.78
9.89
±1.26
11.99
±1.34
12.05
±1.17
1.00 0.97 <0.001
HLA_C ILMN
2150787
6.34
±0.66
6.44
±0.37
6.44
±0.63
6.74
±0.77
0.46 0.51 0.38
HLA_C ILMN
1721113
7.57
±0.95
7.43
±0.58
8.16
±1.19
8.50
±1.12
0.42 0.97 0.013
HLA_E ILMN
1765258
11.01
±1.21
10.81
±0.61
11.82
±1.05
11.71
±0.93
0.63 1.00 <0.001
HLA_F ILMN
1762861
7.72
±1.00
7.49
±0.69
8.58
±1.13
8.54
±1.02
1.00 0.67 <0.001
HLA_G ILMN
1656670
8.32
±1.16
7.73
±0.61
9.00
±0.76
8.96
±0.69
0.85 0.15 <0.001
CD68 ILMN
1714861
10.39
±1.16
10.30
±0.75
11.07
±0.74
10.99
±0.87
0.80 0.85 0.008
CD3D ILMN
2261416
6.92
±1.32
6.61
±0.45
7.23
±1.06
7.41
±1.29
0.85 0.51 0.033
CD3D ILMN
2325837
6.94
±1.39
6.49
±0.47
7.31
±1.17
7.44
±1.29
0.75 0.23 0.016
CD3E ILMN
1739794
6.49
±0.39
6.37
±0.09
6.51
±0.26
6.60
±0.35
0.56 0.41 0.19
CD3G ILMN
1717197
6.60
±0.36
6.58
±0.13
6.61
±0.27
6.60
±0.33
0.70 0.51 0.77
CD8A ILMN
1768482
7.10
±1.59
6.75
±0.58
7.39
±1.17
7.71
±1.43
0.56 0.67 0.061
CD8A ILMN
1760374
6.50
±0.46
6.35
±0.09
6.47
±0.27
6.57
±0.52
0.80 0.41 0.25
CD8A ILMN
2353732
7.00
±1.63
6.62
±0.55
7.35
±1.19
7.64
±1.44
0.52 0.46 0.019
CD4 ILMN
1727284
6.62
±0.41
6.51
±0.21
6.70
±0.25
6.72
±0.40
0.90 0.61 0.036